Quest Diagnostics Incorporated (DGX)

NYSE: DGX · IEX Real-Time Price · USD

136.64

-0.45 (-0.33%)

At close: Jul 2, 2024, 4:00 PM

137.62

+0.98 (0.72%)

After-hours: Jul 2, 2024, 7:59 PM EDT

Quest Diagnostics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1994
Net Income	854	946	1,995	1,431	858	Upgrade
Depreciation & Amortization	439	437	408	361	329	Upgrade
Share-Based Compensation	77	77	79	97	56	Upgrade
Other Operating Activities	-98	258	-249	116	-	Upgrade
Operating Cash Flow	1,272	1,718	2,233	2,005	1,243	Upgrade
Operating Cash Flow Growth	-25.96%	-23.06%	11.37%	61.30%	3.58%	Upgrade
Capital Expenditures	-408	-404	-403	-418	-309	Upgrade
Acquisitions	-611	-144	424	-330	-58	Upgrade
Change in Investments	-42	5	0	-24	-44	Upgrade
Investing Cash Flow	-1,061	-543	21	-772	-411	Upgrade
Dividends Paid	-314	-305	-309	-297	-286	Upgrade
Share Issuance / Repurchase	-203	-1,285	-2,070	-136	-234	Upgrade
Debt Issued / Paid	748	-2	-2	-805	832	Upgrade
Other Financing Activities	-71	-140	-159	-29	-87	Upgrade
Financing Cash Flow	160	-1,732	-2,540	-1,267	225	Upgrade
Net Cash Flow	371	-557	-286	-34	1,057	Upgrade
Free Cash Flow	864	1,314	1,830	1,587	934	Upgrade
Free Cash Flow Growth	-34.25%	-28.20%	15.31%	69.91%	14.04%	Upgrade
Free Cash Flow Margin	9.34%	13.30%	16.96%	16.82%	12.09%	Upgrade
Free Cash Flow Per Share	7.68	11.54	14.92	11.78	6.93	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).